Patients lose sight after stem cell injection in eyes

17 Mar 2017

1

An unproven stem cell treatment for failing eyesight had led to severe, permanent eye damage in three patients, all women, in Sunrise, Florida.

According to an article published Wednesday in The New England Journal of Medicine, the treatment at an unregulated clinic in the state, had rendered one patient, 72, completely blind due to the stem cell injections.

The other women 78 and 88 lost much of their eyesight.  Before the procedure, though, all and some impairment, they could still see well enough to drive.

The women suffered from macular degeneration, an eye disease that caused vision loss. The treatment cost them $5,000 each. The clinic was part of a company called Bioheart, but is now known as US Stem Cell. At the clinic, fat was sucked out of the women's bellies, by liposuction and then stem cells extracted from the fat were injected into the women's eyes.

The disastrous results are described in detail by doctors not connected to US Stem Cell in the journal article. The doctors had treated the patients within days of the injections.

In an accompanying article, scientists from the Food and Drug Administration warned that stem cells from fat ''are being used in practice on the basis of minimal clinical evidence of safety or efficacy, sometimes with the claims that they constitute revolutionary treatments for various conditions.''

This was not the first time people had come to grievous harm after undergoing unproven treatments purportedly involving stem cells. In 2010, a woman with the autoimmune disease lupus died after her own bone marrow cells were injected into her kidneys at a clinic in Thailand.

More recently, in 2013, a 69-year-old woman died after material extracted from her bone marrow was infused into the arteries feeding her brain. The woman suffered a stroke, and died shortly afterwards.

Latest articles

Musk ramps up SpaceX moon plans as Bezos accelerates Blue Origin in race against China

Musk ramps up SpaceX moon plans as Bezos accelerates Blue Origin in race against China

Indians can now travel to 56 destinations without prior visa as passport ranking improves

Indians can now travel to 56 destinations without prior visa as passport ranking improves

CEO says EU’s IRIS2 must match Starlink on price and performance

CEO says EU’s IRIS2 must match Starlink on price and performance

Applied Materials jumps 12% as AI chip demand drives strong revenue forecast

Applied Materials jumps 12% as AI chip demand drives strong revenue forecast

Opening the silos: India approves 3 million tonnes of wheat and product exports

Opening the silos: India approves 3 million tonnes of wheat and product exports

Capgemini beats 2025 revenue target as WNS acquisition boosts AI-driven growth

Capgemini beats 2025 revenue target as WNS acquisition boosts AI-driven growth

The deregulation “holy grail”: Trump EPA dismantles the legal bedrock of climate policy

The deregulation “holy grail”: Trump EPA dismantles the legal bedrock of climate policy

France-backed Eutelsat beats revenue estimates as Starlink rivalry intensifies

France-backed Eutelsat beats revenue estimates as Starlink rivalry intensifies

Germany’s Stark reportedly crosses €1 billion valuation after fresh funding round

Germany’s Stark reportedly crosses €1 billion valuation after fresh funding round